SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes(California Institute of Technology), Claudia A. Jette(California Institute of Technology), Morgan E. Abernathy(California Institute of Technology), Kim-Marie A. Dam(California Institute of Technology), Shannon R. Esswein(California Institute of Technology), Harry B. Gristick(California Institute of Technology), Andrey Malyutin(California Institute of Technology), Naima G. Sharaf(California Institute of Technology), Kathryn E. Huey‐Tubman(California Institute of Technology), Yu E. Lee(California Institute of Technology), Davide F. Robbiani(Università della Svizzera italiana), Michel C. Nussenzweig(Howard Hughes Medical Institute), Anthony P. West(California Institute of Technology), Pamela J. Björkman(California Institute of Technology)
Cited by 1,862Open Access
Abstract
Related Papers
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al.|Acta Crystallographica Section D Biological Crystallography|2010|29.4k
<i>PHENIX</i>: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams, Pavel V. Afonine, G. Bunkóczi et al.|Acta Crystallographica Section D Biological Crystallography|2010|24.4k
<i>Phaser</i>crystallographic software
Airlie J. McCoy, Ralf W. Grosse‐Kunstleve, Paul D. Adams et al.|Journal of Applied Crystallography|2007|20.8k
<i>MolProbity</i>: all-atom structure validation for macromolecular crystallography
Vincent B. Chen, W.B. Arendall, Jeffrey J. Headd et al.|Acta Crystallographica Section D Biological Crystallography|2009|14.6k
Overview of the<i>CCP</i>4 suite and current developments
Martyn Winn, Charles Ballard, Kevin Cowtan et al.|Acta Crystallographica Section D Biological Crystallography|2011|12.5k